ClinicalTrials.Veeva

Menu

Coronary Bifurcation Stenting (COBIS) Registry in South Korea

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Coronary Bifurcation Lesion

Study type

Observational

Funder types

Other

Identifiers

NCT00851526
2007-04-042

Details and patient eligibility

About

The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea.

The aim of the study was to find out the current status of bifurcation drug-eluting stenting and determine the prognostic factors for long-term outcome in South Korea.

Enrollment

1,919 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >= 18 years
  • Any type of de novo bifurcation lesion with a parent vessel >= 2.5 mm and side branch>= 2.0 mm by visual estimation
  • Treated with drug-eluting stent

Exclusion criteria

  • Cardiogenic Shock
  • ST elevation MI within 48hours
  • Expected survival less than 1 year
  • Left main bifurcation
  • Allergy to the antiplatelets

Trial design

1,919 participants in 1 patient group

Coronary bifurcation lesion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems